Novaawell Pharmaceuticals has entered a landmark partnership with the World Health Organisation to expand vaccine access in underserved regions. The initiative will cover 20 countries across Sub-Saharan Africa and Southeast Asia, with a focus on cold-chain logistics innovation and community health worker training. By leveraging our global distribution network and WHO’s on-ground expertise, we aim to immunise over 5 million individuals within the first 18 months.
news